@CellingAlpha

Tweets about biomedical sciences and finance. Ph.D., Not financial advice. Do your own research.

Joined March 2022
  • Tweets263
  • Following2.7K
  • Followers164
22Media
tcoyd.org/2026/08/type-1-dia…

The Race for a Type 1 Diabetes Cure Is Heating Up!

Finally, a cure for type 1 diabetes could be just around the corner. Learn how islet cell transplant could finally make it possible. Read more!

tcoyd.org
8
Celling Alpha retweeted
UC Berkeley
@UCBerkeleyAug 21
UC Berkeley scientists identified a promising molecular compound that could lead to a new weight loss and diabetes treatment. Unlike GLP-1s, it helps cells burn extra energy while preserving muscle, without changing food intake or exercise. bit.ly/4xhpQTI

A promising new weight loss and diabetes treatment helps burn fat while keeping muscle - Berkeley...

Unlike GLP-1s, which work by suppressing appetite and lowering energy intake, a molecular compound identified by UC Berkeley scientists helps cells burn extra energy with no change in food intake or...

news.berkeley.edu
1
11
3
64
9,207
Celling Alpha retweeted
Profluent
@ProfluentBioApr 28
Today we announced a landmark partnership with @EliLillyandCo to use our AI models to design recombinases for genetic medicine—a collaboration valued at up to $2.25 billion before royalties. The goal: use Profluent's AI models to design recombinase editors capable of inserting long stretches of DNA at precise locations in the genome. Read the press release for more: businesswire.com/news/home/2…
6
14
5
120
22,303
This might be the biggest breakthrough in pancreatic cancer in decades - National Geographic apple.news/AnjMMvxeZS3uCsqy4…
9
news.mit.edu/2026/implantabl…

Implantable islet cells could control diabetes without insulin injections

As an alternative to insulin injections, MIT researchers are developing an implantable device that encapsulates islet cells, protecting them from immune rejection. The device also carries an oxygen...

news.mit.edu
11
Toward Replacing Lost β-Cells in Type 1 Diabetes Stem cell–derived islet therapy reported in three recipients with complete pretransplant β-cell loss. thelancet.com/action/showPdf…
1
15
medicaleconomics.com/view/de…

Dexcom Smart Basal wins FDA Clearance for Type 2 diabetes insulin support | Medical Economics

Dexcom Smart Basal optimizes insulin dosing for Type 2 diabetes, integrating CGM data for personalized recommendations and enhancing patient care efficiency.

medicaleconomics.com
17
First 5 Patients with 'Brittle' T1D are Insulin-Free einpresswire.com/article/861…

First 5 Patients with 'Brittle' T1D are Insulin-Free

Breaking News from 2025 Congress of Cell Transplantation and Regenerative Medicine Society

einpresswire.com
15
One-Time Gene Therapy Cures ADA-SCID, Offering Lasting, Donor-Free Solution newatlas.com/disease/ada-sci…

95% of kids with “bubble boy” disease cured by one-time gene therapy

A one-time gene therapy using a patient’s own stem cells has effectively cured a deadly immune disorder in 95% of treated children, offering a lasting, donor-free solution to ADA-SCID, known as the...

newatlas.com
14
A promising drug target for regenerating functional β-cell mass in diabetes! @WorthamLab, @msanderlab & team @UCSanDiego discover the deacetylase SIRT2 restrains proliferation of pancreatic β-cells in a glucose-dependent manner: jci.org/articles/view/187020 The image shows labeling of SIRT2 (red), insulin (green), and nuclei staining (blue) in mouse pancreatic islet sections.
1
5
26
2,646
Son’s diabetes diagnosis sent scientist on quest for cure — Harvard Gazette news.harvard.edu/gazette/sto…

Son’s diabetes diagnosis sent scientist on quest for cure — Harvard Gazette

Decades later, Doug Melton and his team are testing a new treatment that could make insulin shots obsolete.

news.harvard.edu
8
Yeztugo® (Lenacapavir) Is Now the First and Only FDA-Approved HIV Prevention Option Offering 6 Months of Protection gilead.com/news/news-details… via @Gilead

Yeztugo® (Lenacapavir) Is Now the First and Only FDA Approved HIV Prevention Option Offering 6...

Yeztugo® (Lenacapavir) Is Now the First and Only FDA Approved HIV Prevention Option Offering 6 Months of Protection

gilead.com
20
Strong article from Tom Maniatis, head of the NY Genome Center, on the history of the NIH and its role in maintaining U.S. scientific leadership. Safeguarding the future of biomedical science in the United States: Cell cell.com/cell/fulltext/S0092…

Safeguarding the future of biomedical science in the United States

NIH’s abrupt decision to cap indirect cost reimbursement at 15% threatens the critical infrastructure supporting groundbreaking biomedical research in the United States. This policy jeopardizes...

cell.com
4
121
3
307
30,572
FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes fda.gov/news-events/press-an…

FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes

FDA approved the first rapid-acting biosimilar insulin product, Merilog (insulin-aspart-szij), to improve glycemic control in adults and children with diabetes

fda.gov
12
FDA Proposes Framework to Advance Credibility of AI Models Used for Drug and Biological Product Submissions fda.gov/news-events/press-an…

FDA Proposes Framework to Advance Credibility of AI Models Used for Drug and Biological Product...

The FDA issued draft guidance to provide recommendations on the use of artificial intelligence intended to support a regulatory decision about a drug or biologi

fda.gov
7
Celling Alpha retweeted
Eric Topol
@EricTopol3 Jan 2025
Unprecedented protection from malaria (90%) from a single shot vaccine: results of a small randomized trial @NatureMedicine nature.com/articles/s41591-0… nature.com/articles/s41591-0…

Single immunization with genetically attenuated Pf∆mei2 (GA2) parasites by mosquito bite in...

Nature Medicine - In a small randomized controlled clinical trial, a single immunization for malaria using mosquitoes infected with attenuated parasites showed unprecedented 90% protective efficacy...

nature.com
181
14
577
38,639
Harvard Professors Leaving for Private Sector Research | Harvard Magazine harvardmagazine.com/2025/01/…

Harvard Professors Leaving for Private Sector Research | Harvard Magazine

Three distinguished scientists on leaving academia to advance biomedical research

harvardmagazine.com
5
FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes fda.gov/news-events/press-an…
9
Celling Alpha retweeted
nature
@Nature16 Oct 2024
Scientists have designed a new form of insulin that can automatically switch itself on and off depending on glucose levels in the blood go.nature.com/3A14Yrk

‘Smart’ insulin prevents diabetic highs — and deadly lows

Nature - In animals, the molecule automatically reduced blood-sugar levels without causing them to dip too much.

nature.com
15
510
86
1,569
134,247
‘Smart’ insulin prevents diabetic highs — and deadly lows nature.com/articles/d41586-0…

‘Smart’ insulin prevents diabetic highs — and deadly lows

Nature - In animals, the molecule automatically reduced blood-sugar levels without causing them to dip too much.

nature.com
9
Load more